Jennison Associates’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-162,550
| Closed | -$15.1M | – | 690 |
|
|
2021
Q1 | $15.1M | Sell |
162,550
-231,924
| -59% | -$21.5M | 0.01% | 385 |
|
|
2020
Q4 | $35.3M | Sell |
394,474
-58,174
| -13% | -$5.21M | 0.03% | 266 |
|
|
2020
Q3 | $46.8M | Buy |
452,648
+2,164
| +0.5% | +$224K | 0.04% | 192 |
|
|
2020
Q2 | $35.6M | Sell |
450,484
-81,250
| -15% | -$6.43M | 0.03% | 213 |
|
|
2020
Q1 | $30.8M | Sell |
531,734
-110,313
| -17% | -$6.38M | 0.04% | 197 |
|
|
2019
Q4 | $34.6M | Buy |
642,047
+59,938
| +10% | +$3.23M | 0.03% | 232 |
|
|
2019
Q3 | $30.4M | Buy |
582,109
+19,988
| +4% | +$1.04M | 0.03% | 259 |
|
|
2019
Q2 | $27.2M | Buy |
562,121
+372,857
| +197% | +$18M | 0.03% | 295 |
|
|
2019
Q1 | $9.56M | Buy |
+189,264
| New | +$9.56M | 0.01% | 426 |
|